Pantoprazole |
Protonix |
Clinical Trial: Study Evaluating Pantoprazole in Children with GERD
This study is currently recruiting patients.
Verified by Wyeth August 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Gastroesophageal Reflux | Drug: Pantoprazole for approximately 9 weeks. | Phase I |
MedlinePlus related topics: Gastroesophageal Reflux/Hiatal Hernia
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Dose Comparison, Single Group Assignment, Pharmacokinetics Study
Official Title: A Multicenter, Randomized, Open Label, Single, and Multiple Dose Study of the Safety and Pharmacokinetics of 2 Dose Levels of Pantoprazole Sodium in Children Aged 1 Through 11 Years with Endoscopically Proven GERD.
Secondary Outcomes: Assessment of safety and tolerability of pantoprazole and assessment of growth parameters
Expected Total Enrollment: 30
Study start: August 2005
Eligibility
Inclusion Criteria:
- Endoscopically proven GERD diagnosed within 6 months before study entry.
- Weight must be equal to or over 8.3 kg; for subjects 6 years or greater, weight must be equal to or under 25 kg
Exclusion Criteria:
- History of GI disorders, ie, unrepaired tracheal esophageal fistula, GI malabsorption, Eosinophilic esophagitis
- Subjects 6-11 years old unable to swallow tablets
Location and Contact Information
California
San Diego, California, 92103, United States; Recruiting
District of Columbia
Washington, District of Columbia, 20010, United States; Recruiting
Florida
Gainesville, Florida, 32610, United States; Recruiting
Illinois
Park Ridge, Illinois, 60068, United States; Recruiting
Indiana
Indianapolis, Indiana, 46202, United States; Recruiting
Kentucky
Louisville, Kentucky, 40202, United States; Recruiting
Massachusetts
Brockton, Massachusetts, 02302, United States; Recruiting
Boston, Massachusetts, 02115, United States; Recruiting
Boston, Massachusetts, 02114, United States; Recruiting
Michigan
Detroit, Michigan, 48201, United States; Recruiting
Mississippi
Jackson, Mississippi, 39216, United States; Recruiting
Missouri
Kansas City, Missouri, 64108, United States; Recruiting
New York
New York, New York, 10032, United States; Recruiting
Texas
Temple, Texas, 76508, United States; Recruiting
Utah
Salt Lake City, Utah, 84113, United States; Recruiting
Wisconsin
Milwaukee, Wisconsin, 53226, United States; Recruiting
Medical Monitor, Study Director, Wyeth Research
More Information
Last Updated: September 1, 2005
Record first received: August 30, 2005
ClinicalTrials.gov Identifier: NCT00141817
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-06
Resources
- Pantoprazole (Drug Digest)
- Protonix (Drug Digest)

Not Signed In -

